, 29 May 2019
A Fear Memory Engram and its Plasticity in the Hypothalamic Oxytocin System
>> Free access until August 22 clicking on this link
Hasan MT 1 , Althammer F 2 , Silva da Gouveia M 2 , Goyon S 3 , Eliava M 2 , Lefevre A 2 , Kerspern D 3 , Schimmer J 2 , Raftogianni A 2 , Wahis J 3 , Knobloch-Bollmann HS 2 , Tang Y 2 , Liu X 2 , Jain A 2 , Chavant V 3 , Goumon Y 3 , Weislogel JM 4 , Hurlemann R 5 , Herpertz SC 6 , Pitzer C 7 , Darbon P 3 , Dogbevia GK 8 , Bertocchi I 9 , Larkum ME 10 , Sprengel R 9 , Bading H 4 , Charlet A 11 , Grinevich V 12
Oxytocin (OT) release by axonal terminals onto the central nucleus of the amygdala exerts anxiolysis. To investigate which subpopulation of OT neurons contributes to this effect, we developed a novel method: virus-delivered genetic activity-induced tagging of cell ensembles (vGATE). With the vGATE method, we identified and permanently tagged a small subpopulation of OT cells, which, by optogenetic stimulation, strongly attenuated contextual fear-induced freezing, and pharmacogenetic silencing of tagged OT neurons impaired context-specific fear extinction, demonstrating that the tagged OT neurons are sufficient and necessary, respectively, to control contextual fear.
Intriguingly, OT cell terminals of fear-experienced rats displayed enhanced glutamate release in the amygdala. Furthermore, rats exposed to another round of fear conditioning displayed 5-fold more activated magnocellular OT neurons in a novel environment than a familiar one, possibly for a generalized fear response. Thus, our results provide first evidence that hypothalamic OT neurons represent a fear memory engram.
B) The vast majority of OT neurons (99.4% ± 0.8%, green) of the PVN and SON were labeled via a constitutive OT promoter driving hChR2-mCherry (B1, red).
B2) Fear expression induced tagging (ChR2-mCherry, red) of a small population of OT neurons (green). (B1 and B2) Vertical panels depict ChR2-mCherry-containing axons (red) with OT-immunopositive puncta (green, appearing in yellow) in the CeL of both groups.
1 Laboratory of Memory Circuits, Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Sede Building, Barrio Sarriena, 48940 Leioa, Spain; Ikerbasque-Basque Foundation for Science, 48013 Bilbao, Spain; Neurocure, Charité-Universitätsmedizin, Virchowweg 6, 10117 Berlin, Germany; Max Planck Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg, Germany. Electronic address: firstname.lastname@example.org.
2 Schaller Research Group on Neuropeptides, German Cancer Research Center, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany.
3 Centre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neurosciences, 8 Allée du Général Rouvillois, 67000 Strasbourg, France.
4 Department of Neurobiology, Heidelberg University, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany.
5 Department of Psychiatry and Division of Medical Psychology, University of Bonn Medical Center, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany.
6 Department of General Psychiatry, Center of Psychosocial Medicine, Heidelberg University, Voßstraße 4, 69115 Heidelberg, Germany.
7 Interdisciplinary Neurobehavioral Core (INBC), Heidelberg University, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.
8 Max Planck Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg, Germany.
9 University of Torino, Department of Neuroscience Rita Levi Montalcini and Neuroscience Institute Cavalieri Ottolenghi (NICO), Orbassano, 10043, Torino, Italy.
10 Neurocure, Charité-Universitätsmedizin, Virchowweg 6, 10117 Berlin, Germany.
11 Centre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neurosciences, 8 Allée du Général Rouvillois, 67000 Strasbourg, France; University of Strasbourg Institute for Advanced Study (USIAS), Strasbourg, France. Electronic address: email@example.com.
12 Schaller Research Group on Neuropeptides, German Cancer Research Center, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany; Department of Neuropeptide Research for Psychiatry, Central Institute of Mental Health, Heidelberg University, J5, 68159 Mannheim, Germany. Electronic address: firstname.lastname@example.org.
Events & Meetings
Workshop on GLIAL CELLS-NEURON CROSSTALK will take place from 1st to 3rd October 2020 :: Update coming soon.